litlas
Log inCreate account

April W. Armstrong

Active 2001–2025

Also published as
April W Armstrong
196
Papers
28,159
Citations
82
h-index
178
i10-index

Citations

Citations per year for April W. Armstrong1964: 1 citations1985: 1 citations1986: 3 citations2002: 2 citations2004: 4 citations2005: 10 citations2006: 2 citations2007: 4 citations2008: 2 citations2009: 8 citations2010: 25 citations2011: 15 citations2012: 42 citations2013: 74 citations2014: 118 citations2015: 120 citations2016: 144 citations2017: 202 citations2018: 232 citations2019: 790 citations2020: 995 citations2021: 1,235 citations2022: 1,177 citations2023: 1,082 citations2024: 1,947 citations2025: 975 citations2026: 12 citations1965–1984: no citations, so these years are not shown1987–2001: no citations, so these years are not shown2003: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,279 citing papers, 20.8% of this breakdownChina: 1,116 citing papers, 10.2% of this breakdownUnited Kingdom: 746 citing papers, 6.8% of this breakdownGermany: 725 citing papers, 6.6% of this breakdownItaly: 628 citing papers, 5.7% of this breakdownCanada: 583 citing papers, 5.3% of this breakdownSpain: 396 citing papers, 3.6% of this breakdownFrance: 359 citing papers, 3.3% of this breakdownJapan: 323 citing papers, 3% of this breakdownDenmark: 298 citing papers, 2.7% of this breakdownSwitzerland: 257 citing papers, 2.4% of this breakdownNetherlands: 255 citing papers, 2.3% of this breakdown
0%20.8%Other 27.3%

Institutions

Fields

  • Medicine46.2%
  • Immunology and Microbiology40.1%
  • Biochemistry, Genetics and Molecular Biology5.8%
  • Pharmacology, Toxicology and Pharmaceutics2%
  • Health Professions1.3%
  • Neuroscience0.8%
  • Other3.8%

Topics

  • Psoriasis: Treatment and Pathogenesis17.9%
  • Dermatology and Skin Diseases11.1%
  • Spondyloarthritis Studies and Treatments7.6%
  • Rheumatoid Arthritis Research and Therapies3.1%
  • Asthma and respiratory diseases2.8%
  • Allergic Rhinitis and Sensitization2.2%
  • Other55.3%

Coauthors

All papers

Open in search
  1. Psoriasis

    Authors: C.E.M. Griffiths, April W. Armstrong, Jóhann E. Guðjónsson, Jonathan N W N Barker - The Lancet 2021 cited by 2,243

  2. Pathophysiology, Clinical Presentation, and Treatment of Psoriasis

    Authors: April W. Armstrong, Charlotte Read - JAMA 2020 cited by 2,219

  3. Deucravacitinib versus placebo and apremilast in moderate to severe plaque psoriasis: Efficacy and safety results from the 52-week, randomized, double-blinded, placebo-controlled phase 3 POETYK PSO-1 trial

    Authors: April W. Armstrong, Melinda Gooderham, Richard B. Warren, Kim Papp, Bruce Strober, Diamant Thaçi, Akimichi Morita, Jacek C. Szepietowski, Shinichi Imafuku, Elizabeth Colston, John Throup, Sudeep Kundu, Steve Schoenfeld, Misti Linaberry, Subhashis Banerjee, Andrew Blauvelt - Journal of the American Academy of Dermatology 2022 cited by 347

  4. Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics

    Authors: Alan Menter, Bruce Strober, Daniel H. Kaplan, Darío Kivelevitch, Elizabeth Farley Prater, Benjamin K. Stoff, April W. Armstrong, Cody Connor, Kelly M. Cordoro, Dawn Marie R. Davis, Boni E. Elewski, Joel M. Gelfand, Kenneth B. Gordon, Alice B. Gottlieb, Arthur Kavanaugh, Matthew Kiselica, Neil J. Korman, Daniela Kroshinsky, Mark Lebwohl, Craig L. Leonardi, Jason Lichten, Henry W. Lim, Nehal N. Mehta, Amy S. Paller, Sylvia L. Parra, Arun L. Pathy, Reena Rupani, Michael Siegel, Emily Wong, Jashin J. Wu, Vidhya Hariharan, Craig A. Elmets - Journal of the American Academy of Dermatology 2019 cited by 924

  5. Psoriasis Prevalence in Adults in the United States

    Authors: April W. Armstrong, Manan D. Mehta, Clayton W. Schupp, George Gondo, Stacie Bell, C.E.M. Griffiths - JAMA Dermatology 2021 cited by 460

  6. Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the treatment of patients with moderate to severe psoriasis with randomized withdrawal and retreatment: Results from the phase III, double-blind, placebo- and active comparator–controlled VOYAGE 2 trial

    Authors: Kristian Reich, April W. Armstrong, Peter Foley, Michael Song, Yasmine Wasfi, B. Randazzo, Shu Li, Yaung‐Kaung Shen, Kenneth B. Gordon - Journal of the American Academy of Dermatology 2017 cited by 731

  7. Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa

    Authors: Alexa B. Kimball, Martin M. Okun, David Williams, Alice B. Gottlieb, Kim Papp, Christos C. Zouboulis, April W. Armstrong, Francisco A. Kerdel, Michael H. Gold, Seth Forman, Neil J. Korman, Evangelos J. Giamarellos‐Bourboulis, Jeffrey Crowley, Charles Lynde, Z. Reguiaï, Errol-Prospero Prens, Eihab Alwawi, Nael M. Mostafa, Brett Pinsky, Murali Sundaram, Yihua Gu, Dawn M. Carlson, Gregor B. E. Jemec - New England Journal of Medicine 2016 cited by 777

  8. Guselkumab versus secukinumab for the treatment of moderate-to-severe psoriasis (ECLIPSE): results from a phase 3, randomised controlled trial

    Authors: Kristian Reich, April W. Armstrong, Richard G. Langley, Susan Flavin, B. Randazzo, Shu Li, Ming-Chun Hsu, Patrick Branigan, Andrew Blauvelt - The Lancet 2019 cited by 376

  9. Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities

    Authors: Craig A. Elmets, Craig L. Leonardi, Dawn Marie R. Davis, Joel M. Gelfand, Jason Lichten, Nehal N. Mehta, April W. Armstrong, Cody Connor, Kelly M. Cordoro, Boni E. Elewski, Kenneth B. Gordon, Alice B. Gottlieb, Daniel H. Kaplan, Arthur Kavanaugh, Darío Kivelevitch, Matthew Kiselica, Neil J. Korman, Daniela Kroshinsky, Mark Lebwohl, Henry W. Lim, Amy S. Paller, Sylvia L. Parra, Arun L. Pathy, Elizabeth Farley Prater, Reena Rupani, Michael Siegel, Benjamin K. Stoff, Bruce Strober, Emily Wong, Jashin J. Wu, Vidhya Hariharan, Alan Menter - Journal of the American Academy of Dermatology 2019 cited by 486

  10. Bimekizumab versus ustekinumab for the treatment of moderate to severe plaque psoriasis (BE VIVID): efficacy and safety from a 52-week, multicentre, double-blind, active comparator and placebo controlled phase 3 trial

    Authors: Kristian Reich, Kim Papp, Andrew Blauvelt, Richard G. Langley, April W. Armstrong, Richard B. Warren, Kenneth B. Gordon, Joseph F. Merola, Yukari Okubo, Cynthia Madden, Maggie Haitian Wang, Christopher L. Cioffi, Veerle Vanvoorden, Mark Lebwohl - The Lancet 2021 cited by 297

  11. Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis

    Authors: Mark Lebwohl, Bruce Strober, Alan Menter, Kenneth B. Gordon, Jolanta Węgłowska, L. Puig, Kim Papp, Lynda Spelman, Darryl Toth, Francisco A. Kerdel, April W. Armstrong, Georg Stingl, Alexa B. Kimball, H. Bachelez, Jashin J. Wu, Jeffrey Crowley, Richard G. Langley, Tomasz Blicharski, C. Paul, J.‐P. Lacour, Stephen K. Tyring, Leon Kircik, Sergio Chimenti, Kristina Callis Duffin, Jerry Bagel, John Koo, Gary Aras, Joanne Li, Wenjie Song, Cassandra E. Milmont, Yifei Shi, Ngozi Erondu, Paul Klekotka, Brian L. Kotzin, Ajay Nirula - New England Journal of Medicine 2015 cited by 806

  12. Joint AAD–NPF Guidelines of care for the management and treatment of psoriasis with topical therapy and alternative medicine modalities for psoriasis severity measures

    Authors: Craig A. Elmets, Neil J. Korman, Elizabeth Farley Prater, Emily Wong, Reena Rupani, Darío Kivelevitch, April W. Armstrong, Cody Connor, Kelly M. Cordoro, Dawn Marie R. Davis, Boni E. Elewski, Joel M. Gelfand, Kenneth B. Gordon, Alice B. Gottlieb, Daniel H. Kaplan, Arthur Kavanaugh, Matthew Kiselica, Daniela Kroshinsky, Mark Lebwohl, Craig L. Leonardi, Jason Lichten, Henry W. Lim, Nehal N. Mehta, Amy S. Paller, Sylvia L. Parra, Arun L. Pathy, Michael Siegel, Benjamin K. Stoff, Bruce Strober, Jashin J. Wu, Vidhya Hariharan, Alan Menter - Journal of the American Academy of Dermatology 2020 cited by 329

  13. Guidelines of care for the management of cutaneous squamous cell carcinoma

    Authors: Murad Alam, April W. Armstrong, Christian L. Baum, Jeremy S. Bordeaux, Marc D. Brown, Klaus J. Busam, Daniel B. Eisen, Vivek Iyengar, Clifford W. Lober, David J. Margolis, Jane L. Messina, Alexander Miller, Stanley J. Miller, Eliot N. Mostow, Christen M. Mowad, Kishwer S. Nehal, Kristi Schmitt-Burr, Aleksandar Sekulić, Paul A. Storrs, Joyce Teng, Siegrid S. Yu, Conway C. Huang, Kevin Boyer, Wendy Smith Begolka, Christopher K. Bichakjian, John Y. S. Kim, Jeffrey H. Kozlow, Bharat B. Mittal, Jeffrey S. Moyer, Thomas Olenecki, Phillip Rodgers - Journal of the American Academy of Dermatology 2018 cited by 581

  14. Joint American Academy of Dermatology–National Psoriasis Foundation guidelines of care for the management of psoriasis with systemic nonbiologic therapies

    Authors: Alan Menter, Joel M. Gelfand, Cody Connor, April W. Armstrong, Kelly M. Cordoro, Dawn Marie R. Davis, Boni E. Elewski, Kenneth B. Gordon, Alice B. Gottlieb, Daniel H. Kaplan, Arthur Kavanaugh, Matthew Kiselica, Darío Kivelevitch, Neil J. Korman, Daniela Kroshinsky, Mark Lebwohl, Craig L. Leonardi, Jason Lichten, Henry W. Lim, Nehal N. Mehta, Amy S. Paller, Sylvia L. Parra, Arun L. Pathy, Elizabeth Farley Prater, Robert S. Rahimi, Reena Rupani, Michael Siegel, Benjamin K. Stoff, Bruce Strober, Elliot B. Tapper, Emily Wong, Jashin J. Wu, Vidhya Hariharan, Craig A. Elmets - Journal of the American Academy of Dermatology 2020 cited by 331

  15. Efficacy and Safety of Lebrikizumab in Combination With Topical Corticosteroids in Adolescents and Adults With Moderate-to-Severe Atopic Dermatitis

    Authors: Eric L. Simpson, Melinda Gooderham, Andreas Wollenberg, Stephan Weidinger, April W. Armstrong, Jennifer Soung, Silvia Mariel Ferrucci, Renata Gontijo Lima, Michael M. Witte, Wen Xu, Hany Elmaraghy, Chitra R Natalie, Evangeline Pierce, Andrew Blauvelt, ADhere Investigators, Abel Jarell, Neil S. Sadick, Howard Sofen, Paul W Wallace, Jose M Carpio, David Greenstein, Angela Moore, Jose M Mendez, Scott Guenthner, Wendy McFalda, Vivian Laquer, Seth Forman, Todd Schlesinger, Andrew Blauvelt, Jeffrey Crowley, Ricardo Tan, Francis J Averill, Rosalyn Elizabeth George, Eddie Armas, Benjamin Lockshin, Jennifer Soung, Walter K. Nahm, Alison Ehrlich, Sunil Dhawan, Eric L. Simpson, Steve Sitar, Jerry Bagel, Phoebe Rich, Bruce Torkan, David F Fivenson, Jamie Weisman, Melody Lynn Stone, April W. Armstrong, Mirwais Saifi, Brad Glick, Melinda Gooderham, Isaiah Day, Lorne Albrecht, Marni Wiseman, David Gratton, Chi-ho Hong, Bernadetta Majorek‐Olechowska, Adam Reich, Beata Kręcisz, Irena Walecka-Herniczek, Jolanta Węgłowska, Beata Bergler‐Czop, Boguslawa Cimoszko, Kamila Padlewska, Maria Czubek, Andreas Pinter, Kristian Reich, Thomas Wildfeuer, Roland Aschoff - JAMA Dermatology 2023 cited by 143

  16. Efficacy and Safety of Lebrikizumab, a High-Affinity Interleukin 13 Inhibitor, in Adults With Moderate to Severe Atopic Dermatitis

    Authors: Emma Guttman‐Yassky, Andrew Blauvelt, Lawrence F. Eichenfield, Amy S. Paller, April W. Armstrong, Janice Drew, Ramanan Gopalan, Eric L. Simpson - JAMA Dermatology 2020 cited by 339

  17. Bimekizumab versus Adalimumab in Plaque Psoriasis

    Authors: Richard B. Warren, Andrew Blauvelt, Jerry Bagel, Kim Papp, Paul S. Yamauchi, April W. Armstrong, Richard G. Langley, Veerle Vanvoorden, Dirk De Cuyper, Christopher L. Cioffi, Luke Peterson, Nancy Cross, Kristian Reich - New England Journal of Medicine 2021 cited by 238

  18. Phase 3 Trials of Tapinarof Cream for Plaque Psoriasis

    Authors: Mark Lebwohl, Linda Stein Gold, Bruce Strober, Kim Papp, April W. Armstrong, Jerry Bagel, Leon Kircik, Benjamin D. Ehst, Hwanhee Hong, Jennifer Soung, Jeff Fromowitz, Scott Guenthner, Stephen C. Piscitelli, David S. Rubenstein, Philip M. Brown, Anna M. Tallman, Robert Bissonnette - New England Journal of Medicine 2021 cited by 178

  19. Tapinarof in the treatment of psoriasis: A review of the unique mechanism of action of a novel therapeutic aryl hydrocarbon receptor–modulating agent

    Authors: Robert Bissonnette, Linda Stein Gold, David S. Rubenstein, Anna M. Tallman, April W. Armstrong - Journal of the American Academy of Dermatology 2020 cited by 174

  20. Comparison of Biologics and Oral Treatments for Plaque Psoriasis

    Authors: April W. Armstrong, L. Puig, Avani Joshi, Martha Skup, David Williams, Junlong Li, Keith A. Betts, Matthias Augustin - JAMA Dermatology 2020 cited by 281

  21. Guidelines of care for the management of basal cell carcinoma

    Authors: Christopher K. Bichakjian, April W. Armstrong, Christian L. Baum, Jeremy S. Bordeaux, Marc D. Brown, Klaus J. Busam, Daniel B. Eisen, Vivek Iyengar, Clifford W. Lober, David J. Margolis, Jane L. Messina, Alexander Miller, Stanley J. Miller, Eliot N. Mostow, Christen M. Mowad, Kishwer S. Nehal, Kristi Schmitt-Burr, Aleksandar Sekulić, Paul A. Storrs, Joyce Teng, Siegrid S. Yu, Conway C. Huang, Kevin Boyer, Wendy Smith Begolka, Murad Alam, John Y. S. Kim, Jeffrey H. Kozlow, Bharat B. Mittal, Jeffrey S. Moyer, Thomas Olencki, Phillip Rodgers - Journal of the American Academy of Dermatology 2018 cited by 480

  22. Chronic spontaneous urticaria: Focus on pathophysiology to unlock treatment advances

    Authors: Allen P. Kaplan, Mark Lebwohl, Ana M. Giménez‐Arnau, Michihiro Hide, April W. Armstrong, Marcus Maurer - Allergy 2022 cited by 157

  23. Psoriasis and Major Adverse Cardiovascular Events: A Systematic Review and Meta‐Analysis of Observational Studies

    Authors: Ehrin J. Armstrong, Caitlin T. Harskamp, April W. Armstrong - Journal of the American Heart Association 2013 cited by 458

  24. Psoriasis and suicidality: A systematic review and meta-analysis

    Authors: Sanminder Singh, Catherine L. Taylor, Heather Kornmehl, April W. Armstrong - Journal of the American Academy of Dermatology 2017 cited by 224